Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium

BACKGROUND: Intravenous (IV) artesunate is the treatment of choice for severe malaria. In Europe, however, no GMP-manufactured product is available and treatment data in European travellers are scarce. Fortunately, artesunate became available in the Netherlands and Belgium through a named patient pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kreeftmeijer-Vegter, Annemarie R, van Genderen, Perry J, Visser, Leo G, Bierman, Wouter FW, Clerinx, Jan, van Veldhuizen, Cees KW, de Vries, Peter J
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3364861/
https://ncbi.nlm.nih.gov/pubmed/22462806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-11-102
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars